These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 9516076)

  • 1. Role of IGF-I in normal mammary development.
    Kleinberg DL
    Breast Cancer Res Treat; 1998 Feb; 47(3):201-8. PubMed ID: 9516076
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Insulin-like growth factor I is essential for terminal end bud formation and ductal morphogenesis during mammary development.
    Ruan W; Kleinberg DL
    Endocrinology; 1999 Nov; 140(11):5075-81. PubMed ID: 10537134
    [TBL] [Abstract][Full Text] [Related]  

  • 3. IGF-I: an essential factor in terminal end bud formation and ductal morphogenesis.
    Kleinberg DL; Feldman M; Ruan W
    J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):7-17. PubMed ID: 10791764
    [TBL] [Abstract][Full Text] [Related]  

  • 4. IGF-I, GH, and sex steroid effects in normal mammary gland development.
    Kleinberg DL; Ruan W
    J Mammary Gland Biol Neoplasia; 2008 Dec; 13(4):353-60. PubMed ID: 19034633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Estradiol enhances the stimulatory effect of insulin-like growth factor-I (IGF-I) on mammary development and growth hormone-induced IGF-I messenger ribonucleic acid.
    Ruan W; Catanese V; Wieczorek R; Feldman M; Kleinberg DL
    Endocrinology; 1995 Mar; 136(3):1296-302. PubMed ID: 7867584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evidence that the mammary fat pad mediates the action of growth hormone in mammary gland development.
    Walden PD; Ruan W; Feldman M; Kleinberg DL
    Endocrinology; 1998 Feb; 139(2):659-62. PubMed ID: 9449638
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mammary gland branching morphogenesis is diminished in mice with a deficiency of insulin-like growth factor-I (IGF-I), but not in mice with a liver-specific deletion of IGF-I.
    Richards RG; Klotz DM; Walker MP; Diaugustine RP
    Endocrinology; 2004 Jul; 145(7):3106-10. PubMed ID: 15059953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The expression of the IGF family and GH receptor in the bovine mammary gland.
    Plath-Gabler A; Gabler C; Sinowatz F; Berisha B; Schams D
    J Endocrinol; 2001 Jan; 168(1):39-48. PubMed ID: 11139768
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of the insulin-like growth factor binding proteins during postnatal development of the murine mammary gland.
    Allar MA; Wood TL
    Endocrinology; 2004 May; 145(5):2467-77. PubMed ID: 14749361
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Intact and amino-terminally shortened forms of insulin-like growth factor I induce mammary gland differentiation and development.
    Ruan W; Newman CB; Kleinberg DL
    Proc Natl Acad Sci U S A; 1992 Nov; 89(22):10872-6. PubMed ID: 1438291
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The insulin-like growth factors (IGFs) and IGF binding proteins in postnatal development of murine mammary glands.
    Wood TL; Richert MM; Stull MA; Allar MA
    J Mammary Gland Biol Neoplasia; 2000 Jan; 5(1):31-42. PubMed ID: 10791766
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Insulin-like growth factor binding protein-5 (IGFBP-5) induces premature cell death in the mammary glands of transgenic mice.
    Tonner E; Barber MC; Allan GJ; Beattie J; Webster J; Whitelaw CB; Flint DJ
    Development; 2002 Oct; 129(19):4547-57. PubMed ID: 12223411
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Local insulin-like growth factor-II mediates prolactin-induced mammary gland development.
    Hovey RC; Harris J; Hadsell DL; Lee AV; Ormandy CJ; Vonderhaar BK
    Mol Endocrinol; 2003 Mar; 17(3):460-71. PubMed ID: 12554791
    [TBL] [Abstract][Full Text] [Related]  

  • 14. SOM230 inhibits insulin-like growth factor-I action in mammary gland development by pituitary independent mechanism: mediated through somatostatin subtype receptor 3?
    Ruan W; Fahlbusch F; Clemmons DR; Monaco ME; Walden PD; Silva AP; Schmid HA; Kleinberg DL
    Mol Endocrinol; 2006 Feb; 20(2):426-36. PubMed ID: 16223973
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Growth hormone and insulin-like growth factor-I in the transition from normal mammary development to preneoplastic mammary lesions.
    Kleinberg DL; Wood TL; Furth PA; Lee AV
    Endocr Rev; 2009 Feb; 30(1):51-74. PubMed ID: 19075184
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Targeted disruption of the IGF-I receptor gene decreases cellular proliferation in mammary terminal end buds.
    Bonnette SG; Hadsell DL
    Endocrinology; 2001 Nov; 142(11):4937-45. PubMed ID: 11606462
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SirT1 modulates the estrogen-insulin-like growth factor-1 signaling for postnatal development of mammary gland in mice.
    Li H; Rajendran GK; Liu N; Ware C; Rubin BP; Gu Y
    Breast Cancer Res; 2007; 9(1):R1. PubMed ID: 17201918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interactions of prolactin and growth hormone (GH) in the regulation of mammary gland function and epithelial cell survival.
    Flint DJ; Knight CH
    J Mammary Gland Biol Neoplasia; 1997 Jan; 2(1):41-8. PubMed ID: 10887518
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Three dimensional multiphoton imaging of fresh and whole mount developing mouse mammary glands.
    Johnson MD; Mueller SC
    BMC Cancer; 2013 Aug; 13():373. PubMed ID: 23919456
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Targeted expression of des(1-3) human insulin-like growth factor I in transgenic mice influences mammary gland development and IGF-binding protein expression.
    Hadsell DL; Greenberg NM; Fligger JM; Baumrucker CR; Rosen JM
    Endocrinology; 1996 Jan; 137(1):321-30. PubMed ID: 8536631
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.